AC Immune (ACIU) Assets Average (2016 - 2026)

AC Immune (ACIU) has 10 years of Assets Average data on file, last reported at $87.8 billion in Q1 2026.

• On a quarterly basis, Assets Average rose 35151.09% year-over-year to $87.8 billion in Q1 2026; TTM through Mar 2026 was $87.8 billion, a 35151.09% increase from a year earlier, with the FY2025 full-year figure at $224.8 million, down 4.27% from the prior year.
• Assets Average for Q1 2026 stood at $87.8 billion, up from $203.8 million in the prior quarter.
• Over the last five years, Assets Average for ACIU reached as high as $87.8 billion in Q1 2026 and fell as low as $240054.7 in Q2 2022.
• Historically, Assets Average has averaged $5.3 billion across 5 years, with a median of $202.9 million in 2022.
• Across the five-year window, Assets Average surged 74181.33% in 2023 and dropped 25.29% in 2025, its largest moves.
• Year by year, Assets Average stood at $202.9 million in 2022, then retreated by 9.33% to $184.0 million in 2023, then surged by 48.24% to $272.8 million in 2024, then retreated by 25.29% to $203.8 million in 2025, then jumped by 43009.42% to $87.8 billion in 2026.
• Per Business Quant data, the three most recent Assets Average figures were $87.8 billion in Q1 2026, $203.8 million in Q4 2025, and $222.1 million in Q3 2025.